Stryker (SYK) Cash & Equivalents (2009 - 2026)

Stryker (SYK) has 18 years of Cash & Equivalents data on file, last reported at $2.9 billion in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $2.9 billion, up 24.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 24.05% YoY), and the FY2025 annual result was $4.0 billion, up 9.83% from the prior year.
• Cash & Equivalents eased to $2.9 billion in Q1 2026 per SYK's latest filing, from $4.0 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $4.0 billion in Q4 2025 and troughed at $1.0 billion in Q2 2022.
• A 5-year average of $2.4 billion and a median of $2.3 billion in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents slumped 53.41% in 2022, then surged 106.99% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $1.8 billion in 2022, then soared by 61.12% to $3.0 billion in 2023, then climbed by 22.92% to $3.7 billion in 2024, then increased by 9.83% to $4.0 billion in 2025, then dropped by 28.25% to $2.9 billion in 2026.
• Business Quant data shows SYK's Cash & Equivalents at $2.9 billion in Q1 2026, $4.0 billion in Q4 2025, and $3.3 billion in Q3 2025.